Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy

(2016) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

(2015) Feng Shen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B

(2014) Yu-Qiang Mi et al.   DIGESTIVE DISEASES AND SCIENCES

A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis

(2014) Wah-Kheong Chan et al.   Hepatology International

Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males

(2014) Wah-Kheong Chan et al.   Hepatology International

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

(2014) Wah-Kheong Chan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations

(2014) Victor de Lédinghen et al.   JOURNAL OF HEPATOLOGY

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy

(2014) Thomas Karlas et al.   PLoS One

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease

(2014) Kyu Sik Jung et al.   PLoS One

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

(2014) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis

(2014) Giovanna Ferraioli   WORLD JOURNAL OF GASTROENTEROLOGY

Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B

(2014) Chun-Yan Wang   WORLD JOURNAL OF GASTROENTEROLOGY

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

(2014) Feng Shen   WORLD JOURNAL OF GASTROENTEROLOGY

Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

(2013) Keiichi Masaki et al.   HEPATOLOGY RESEARCH

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?

(2013) Manoj Kumar et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

(2013) Wah-Kheong Chan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population

(2013) Young Eun Chon et al.   LIVER INTERNATIONAL

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

(2012) Vincent Wai-Sun Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association

(2012) Naga Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Determination of reliability criteria for liver stiffness evaluation by transient elastography

(2012) Jérôme Boursier et al.   HEPATOLOGY

Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia

(2012) Seok-Chin Goh et al.   Hepatology International

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

(2012) Victor Lédinghen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

(2012) Robert P. Myers et al.   LIVER INTERNATIONAL

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

(2011) Robert P. Myers et al.   HEPATOLOGY

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

(2011) M. Sasso et al.   JOURNAL OF VIRAL HEPATITIS

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY